InvestorsHub Logo
Followers 7
Posts 789
Boards Moderated 0
Alias Born 11/20/2003

Re: BioSpecialist post# 11772

Wednesday, 06/14/2017 8:05:26 PM

Wednesday, June 14, 2017 8:05:26 PM

Post# of 12450
I think that igxt getting a partner with the period of exclusivity for tadafil and a generous would be the catalyst to trigger
and attract investor interest to break $1
based upon 1. the f2f profits
2. The period of exclusivity 3.the potential market share that the product will gain
4. The greater revenue stream and potential if this product can now be purchased OTC without a doctor's prescription since this will be marketed before viagra patent expires.

5. The switchover from viagra to tactful which could be a lot cheaper than viagra
6 The greater upfront partnership payment since I think their past partnered drugs did not receive that much because of the limited revenue possibilities.Tadafil
has access to a significant market.
than their other marketed drugs.

I would like to get a handle on present
revenues on Cialis and viagra combined to get a clear picture of what the benefit to igxt would be

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IGXT News